D.E. Shaw & Co
CODX

D.E. Shaw & Co’s Co-Diagnostics CODX Stock Holding History

D.E. Shaw & Co’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,544
Closed -$51.9K – 4531
2024
Q1 		$51.9K Hold
1,544
– – ﹤0.01% 4051
2023
Q4 		$61.6K Sell
1,544
-2
-0.1% -$71 ﹤0.01% 4013
2023
Q3 		$49.2K Sell
1,546
-212
-12% -$8.01K ﹤0.01% 3918
2023
Q2 		$58.6K Sell
1,758
-87
-5% -$3.33K ﹤0.01% 3868
2023
Q1 		$81.9K Sell
1,845
-300
-14% -$24K ﹤0.01% 3996
2022
Q4 		$162K Sell
2,145
-1,958
-48% -$183K ﹤0.01% 4291
2022
Q3 		$395K Buy
4,103
+2,725
+198% +$381K ﹤0.01% 4184
2022
Q2 		$232K Buy
1,378
+126
+10% +$19.2K ﹤0.01% 4485
2022
Q1 		$232K Buy
1,252
+590
+89% +$122K ﹤0.01% 4780
2021
Q4 		$177K Buy
+662
New +$174K ﹤0.01% 4928
2021
Q3 		– Sell
-1,208
Closed -$299K – 4993
2021
Q2 		$299K Buy
+1,208
New +$311K ﹤0.01% 4280

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

D.E. Shaw & Co's CODX Position: Q2 2024 in Review

D.E. Shaw & Co sold out of Co-Diagnostics (CODX) in Q2 2024, closing a stake of 1,544 shares — an estimated $51.9K sold.

D.E. Shaw & Co first reported a position in CODX in Q2 2021 and held it in 11 quarters. The position peaked at $395K in Q3 2022. 43 funds tracked by Wall St. Rank hold CODX as of Q2 2024.

  • D.E. Shaw & Co reported no remaining Co-Diagnostics position as of Q2 2024 after selling out during the quarter.
  • D.E. Shaw & Co sold 1,544 Co-Diagnostics shares in Q2 2024, an estimated $51.9K.
  • D.E. Shaw & Co first reported a position in Co-Diagnostics in Q2 2021 and held it in 11 quarters.
  • D.E. Shaw & Co's Co-Diagnostics position peaked at $395K in Q3 2022.
  • 43 funds tracked by Wall St. Rank held Co-Diagnostics as of Q2 2024.

Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.